Matica Biotechnology

Matica Biotechnology is an active contract development and manufacturing organization specializing in the production of viral vectors for gene therapies, cell therapies, oncolytic viruses, vaccines, and other advanced biotherapeutics. The company operates a state-of-the-art GMP facility in College Station, Texas with up to 500L scale capacity. It provides end-to-end solutions including process development, GMP production/fill & finish services, product release/stability testing and regulatory support. With over 15 years average staff experience and more than 300 vector projects completed globally—including >36 cell therapy projects—Matica Bio supports its clients from early development through BLA filing using advanced single-use technologies and proprietary platforms like MatiMax™.